IL-17A Inhibition: A Treatment Option for Psoriatic Arthritis With Axial Involvement
Psoriatic arthritis is a progressive, potentially debilitating disease that significantly reduces functioning and quality of life. Early appropriate treatment is essential to delaying structural joint damage that can result in axial involvement and loss of functionality.